Cardiovascular health checks: turning early detection into action across Europe

News & Events

6 May 2026
AUTHOR: Lisa Hillman

CVD remains the European Union’s biggest health challenge. It is responsible for nearly one‑third of deaths and costs €282 billion each year.

Heart failure – a leading cause of avoidable hospitalisations – is a significant contributor to this burden. It is often overlooked because the risk factors and early warning signs go undetected until the damage is advanced. But well‑designed cardiovascular health checks can change this.

Our new call to action sets out how targeted, evidence‑based cardiovascular health checks can strengthen early detection and prevention, supporting the implementation of the EU Safe Hearts Plan. Drawing on evidence and European examples, the report highlights how health checks must be carefully designed to deliver meaningful impact in practice.

Health checks must:

Getting health checks right will shift health systems away from late‑stage crisis management towards more sustainable, prevention‑led care. If done well, they will help reverse the long‑standing failure to predict, prevent and protect people from cardiovascular disease, and reduce avoidable hospital admissions, disability and premature death.

Download the call to action

Tagged:

More from News & Events

New manifesto calls for heart failure to be included in EU c
New manifesto calls for heart failure to be included in EU c...
29 September 2026
On World Heart Day, HFPN launches a new manifesto calling on European policymakers to make sure heart failure is fully integrated into the forthcoming European Union (EU) Council R...
Read article
New research sets out how to strengthen specialist heart fai
New research sets out how to strengthen specialist heart fai...
22 September 2026
The European Journal of Cardiovascular Nursing has published new research by the HFPN identifying urgent policy actions to strengthen specialist heart failure (HF) nursing in Europ...
Read article
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca, Bayer and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership. EU Transparency Register ID: 223430420230-66.